Perspectives on human clinical trials of therapies using iPS cells in Japan: Reaching the forefront of stem-cell therapies

Peipei Song; Yoshinori Inagaki; Yasuhiko Sugawara; Norihiro Kokudo

doi:10.5582/bst.2013.v7.3.157

Commentary

Perspectives on human clinical trials of therapies using iPS cells in Japan: Reaching the forefront of stem-cell therapies

Peipei Song, Yoshinori Inagaki, Yasuhiko Sugawara, Norihiro Kokudo

Author information

Keywords: Induced pluripotent stem cell, age-related maculopathy, clinical trial

JOURNAL FREE ACCESS

2013 Volume 7 Issue 3 Pages 157-158

DOI https://doi.org/10.5582/bst.2013.v7.3.157

Details

Abstract

A research project involving sheets of retinal pigment epithelium constructed from iPS cells derived from patients with age-related maculopathy is one step closer to being approved for clinical trials by the Japanese Government. Now is the time to make therapies using iPS cells clinically available.

Corresponding author

Register with J-STAGE for free!